Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sandra V. Kik, Samuel Schumacher, Daniela Maria Cirillo, Gavin Churchyard, Catharina Boehme, Delia Goletti, Molebogeng X. Rangaka, Claudia M. Denkinger, Christian Lienhardt, Christopher Gilpin, Alberto Matteelli, Frank Cobelens. An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018

Member's Comments

No comment yet.

Related content which might interest you: IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Framework for the evaluation of new tests for tuberculosis infection Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020 Year: 2021 Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016 PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019 Year: 2020 T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018 Year: 2018 How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017 The definition of tuberculosis infection based on the spectrum of tuberculosis disease Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021 Year: 2021 Advancing global programmatic management of latent tuberculosis infection for at risk populations Source: Eur Respir J 2016; 47:1327-1330 Year: 2016 The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis Source: Eur Respir J 2016; 48: 1751-1763 Year: 2016 A new paradigm for classification of disease severity and progression of COPD Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Does radiological lesions extent predict pulmonary tuberculosis outcome? Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006 Results of retrospective-prospective comparison study of different immunologic tests in diagnosis of tuberculosis infection Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 The value of immunological methods in the complex diagnostics of TB in chronic renal failure patients in the terminal stage Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019